The main reason we decided to start this blog is to see if we could connect with others that are in similar trial with experimental medications fighting melanoma and try to share information.
My father was selected to participate in a trial with the drug AZD6244 which is a selective MEK inhibitor developed by Array BioPharma and licensed by AstraZeneca. The theory behind the drug is that it can block a protein that the cancer cells need to grow and survive.
He started the drug yesterday - we would love to share experiences with anyone else out there who is also taking this drug or has taken it in the past.
No comments:
Post a Comment